Company: SLND-WT
Filing Date: 2025-03-05
Form Type: S-3
Source: 0001829126-25-001484
Chunk: 10

Company: Southland Holdings, Inc.
Filing Date: 2025-03-05
Form: S-3
Chunk 10
---
 have been no material changes with respect to the risk factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2024.

<div align='center'>2

USE OF PROCEEDS</div>

All of the Common Stock offered by the Selling Stockholders pursuant to this prospectus will be sold by the Selling Stockholders for their respective accounts. We will not receive any of the proceeds from these sales.

The Selling Stockholders will pay any underwriting discounts and commissions and expenses incurred by the Selling Stockholders for brokerage, accounting, tax or legal services or any other expenses incurred by the Selling Stockholders in disposing of the securities. We will bear the costs, fees and expenses incurred in effecting the registration of the securities covered by this prospectus, including all registration and filing fees, NYSE listing fees and fees and expenses of our counsel and our independent registered public accounting firm.

<div align='center'>3

SELLING STOCKHOLDERS</div>

This prospectus relates to the offer and sale from time to time by the Selling Stockholders (including their pledgees, donees, transferees, assignees, successors and other permitted transferees) of up to 5,942,233 shares of Common Stock, consisting of up to (i) 3,396,233 shares of Common Stock issued to Frank S. Renda in the Private Placement; (ii) 2,215,664 shares of Common Stock issued to Rudy V. Renda in the Private Placement; (iii) 219,002 shares of Common Stock issued to Tim Winn in the Private Placement; and (iv) 111,334 shares of Common Stock issued to Cody Gallarda upon the vesting of certain Restricted Stock Units (“RSUs”). When we refer to the “Selling Stockholders” in this prospectus, we refer to the persons listed in the table below, and the pledgees, donees, transferees, assignees, successors and other permitted transferees that hold any of the Selling Stockholders’ interest in the shares of Common Stock.

The following table sets forth information provided by or on behalf of each Selling Stockholder or otherwise reasonably available to the Company as of February 26, 2025, regarding (i) the aggregate number of shares of Common Stock beneficially owned prior to the offering; (ii) the aggregate number of shares of Common Stock that may be offered from time to time by each Selling Stockholder pursuant to this prospectus and any accompanying